Canadian glaucoma study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change

Archives of Ophthalmology

Volumn 128, Issue 10, 2010, Pages 1249-1255

  Chauhan, Balwantray C ^a   Mikelberg, Frederick S ^b   Artes, Paul H ^a   Balazsi, A Gordon ^c   LeBlanc, Raymond P ^a   Lesk, Mark R ^d   Nicolela, Marcelo T ^a   Trope, Graham E ^e  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PERIMETRY; PRIORITY JOURNAL; RISK FACTOR; SEX; VISUAL FIELD DEFECT; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD;

AGED; ANTIBODIES, ANTICARDIOLIPIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PERIMETRY; PROSPECTIVE STUDIES; RISK FACTORS; TONOMETRY, OCULAR; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS; VISUAL FIELD TESTS;

EID: 77957973994     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.196     Document Type: Article

References (26)

1. Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008;53(suppl 1):S3-S10.
2. Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology. 2008;115(7):1123-1129, e3.
3. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48-56.
4. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 12: baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134(4):499-512.
5. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-720.
6. Drance S, Anderson DR, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131(6):699-708.
7. Chauhan BC, Mikelberg FS, Balaszi AG, LeBlanc RP, Lesk MR, Trope GE; Canadian Glaucoma Study Group. Canadian Glaucoma Study, 2: risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008;126(8):1030-1036.
8. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114(11):1965-1972. (Pubitemid 350016362)
9. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713.
10. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126(4):487-497.
11. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279.
12. Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC. Visual field progression in glaucoma: total vs pattern deviation analyses. Invest Ophthalmol Vis Sci. 2005;46(12):4600-4606.
13. Shigeeda T, Tomidokoro A, Araie M, Koseki N, Yamamoto S. Long-term follow-up of visual field progression after trabeculectomy in progressive normaltension glaucoma. Ophthalmology. 2002;109(4):766-770.
14. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37(7):1419-1428.
15. Anderson DR, Drance SM, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001;108(2):247-253.
16. Heijl A, Bengtsson B, Hyman L, Leske MC; Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology. 2009;116(12):2271-2276.
17. Canadian Glaucoma Study Group. Canadian Glaucoma Study, 1: study design, baseline characteristics, and preliminary analyses. Can J Ophthalmol. 2006;41(5):566-575.
18. Heijl A, Lindgren G, Lindgren A, et al. Extended empirical statistical package for evaluation of single and multiple fields: Statpac 2. In: Mills RP, Heijl A, eds. Perimetry Update 1990/1. New York, NY: Kugler & Ghedini; 1991:303-315.
19. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44(9):3873-3879.
20. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol. 1987;105(11):1544-1549.
21. Bhandari A, Crabb DP, Poinoosawmy D, Fitzke FW, Hitchings RA, Noureddin BN. Effect of surgery on visual field progression in normal-tension glaucoma. Ophthalmology. 1997;104(7):1131-1137.
22. Daugeliene L, Yamamoto T, Kitazawa Y. Effect of trabeculectomy on visual field in progressive normal-tension glaucoma. Jpn J Ophthalmol. 1998;42(4):286-292.
23. Folgar FA, de Moraes CG, Prata TS, et al. Glaucoma surgery decreases the rates of localized and global visual field progression. Am J Ophthalmol. 2010;149(2):258-264.e2.
24. Cochran WG. Errors of measurement in statistics. Technometrics. 1968;10(4):637-666.
25. Artes PH, Chauhan BC. Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res. 2005;24(3):333-354.
26. Strouthidis NG, Scott A, Peter NM, Garway-Heath DF. Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement. Invest Ophthalmol Vis Sci. 2006;47(7):2904-2910. (Pubitemid 351639765)